TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
Back to search
Official data from USPTO
NAL PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
12/07/2021
Trademark type
Combined
Nice classes
5
Filing date
10/24/2008
Registration date
08/10/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/19/2020
Last transaction
10/19/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/10/2008
First use in commerce
05/22/2010
Drawing code
3
Owner type
99
Owner location
HONG KONG, HK
Examiner
I, DAVID C
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of an illustration of an atomic model on the left separated by vertical line with the words "NAL" over the word "PHARMA" to the right of the vertical line.
Holders and representatives
Holders
NAL PHARMACEUTICAL GROUP LIMITED
NAL Pharma Ltd
Representatives
Kevin O'Keefe Accolade IP Ltd.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in urologypain management and oncology
Publications
History of USPTO decisions and trademark events.
38 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/19/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/19/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/19/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/19/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
09/01/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/10/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/04/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/04/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2016
E815
TEAS SECTION 8 & 15 RECEIVED
07/29/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/13/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
07/06/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/03/2010
ALIE
ASSIGNED TO LIE
07/03/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/22/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/17/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/15/2010
IUAF
USE AMENDMENT FILED
05/28/2010
PAPER RECEIVED
05/28/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/01/2009
PUBO
PUBLISHED FOR OPPOSITION
09/08/2009
NPUB
NOTICE OF PUBLICATION
08/19/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2009
ALIE
ASSIGNED TO LIE
08/06/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/28/2009
CPRA
PRIORITY ACTION MAILED
01/28/2009
CPRA
PRIORITY ACTION WRITTEN
01/27/2009
DOCK
ASSIGNED TO EXAMINER
01/27/2009
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
10/29/2008
NWAP
NEW APPLICATION ENTERED
10/28/2008
Continuous trademark protection
Get notified about every new filing that threatens NAL PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.